ASN NEURO - Benefits of publishing

About

Institutional membership

Submit

Authors

Readers

AMERICAN SOCIETY FOR NEUROCHEMISTRY The Latest in Molecular and Cellular Neurobiology


Editorial Board Editor-in-Chief Anthony T. Campagnoni Los Angeles, U.S.A. Deputy Editors-in-Chief Monica Carson Riverside, U.S.A. Christopher S. Colwell Los Angeles, U.S.A. Reviews Editors Scott T. Brady Chicago, U.S.A. Wilma J. Friedman Newark, U.S.A. Senior Editors Susan Y. Bookheimer Los Angeles, U.S.A. Carol A. Colton Durham, U.S.A. Gary Landreth Cleveland, U.S.A. Wendy Macklin Denver, U.S.A. Mary C. McKenna Baltimore, U.S.A. Vladimir Parpura Birmingham, U.S.A. Thomas Seyfried Chestnut Hill, U.S.A. Editorial Board	Benefits of publishing in ASN NEURO One year Impact Factor: 3.833* citations tracked in Science Citation Index and Neuroscience Citation Index Open Access -your research available to all competitive publication fees no additional submission, review or page charges free colour you retain copyright under the Creative Commons Attribution Non-Commercial Licence Member of the Neuroscience Peer Review Consortium if your paper is deemed inappropriate for one of the Consortium member journals, submit your paper and the reviews to ASN NEURO for consideration Independent and fair review process fair, thorough and constructive 'author-friendly' peer review process each paper seen by two reviewers and a Senior Editor Fast review average of 4 weeks for all papers immediate publication of your accepted manuscript following receipt of the open-access publication fee High international visibility average of 600 downloads per paper article level usage metrics available from the journal website electronic table of contents with links to papers distributed widely Fast publication of the final version of record approximately 3 weeks from acceptance to publication Eleven Knowledge Environments choose where your paper appears and connect with your community Multimedia and online data published enhance your paper with embedded video clips � see paper by Osborne et al. No restriction on length unless deemed necessary for clarity, you will not be asked to reduce the length of your paper, remove Figures/Tables or reduce the number of references International Editorial Board Publisher deposits your paper in PubMed Central and notifies you of the PMCID Reference linking extensive reference linking to PubMed CrossRef services Indexing and abstracting included in the major abstracting and indexing services Commitment to quality highly trained staff oversee the editorial and production processes of your paper Not-for-profit publisher published by Portland Press, the wholly owned subsidiary of the Biochemical Society, on behalf of the American Society for Neurochemistry *2010 Journal Citation Reports, Thomson Reuters	RSS feeds Table of contents by email Submit to ASN NEURO Latest Issue Search archive Browse archive Most read papers F1000 Evaluations Immediate publications Reviews Commentaries Instructions to authors Our reviewers ISSN: 1759-0914 Published by Portland Press Limited on behalf of the American Society for Neurochemistry *Publication time subject to receipt of payment †2010 Journal Citation Reports® (Thomson Reuters, 2011)